Enhanced Games results challenge biohacking premise as commercial ties come under scrutiny

The inaugural Enhanced Games, held in Las Vegas, concluded with results that have significantly undermined the event’s core marketing narrative. Despite the premise that legal performance-enhancing drugs would lead to superior athletic outcomes, three of the four unenhanced athletes defeated their enhanced rivals in their respective races. Only one world record was broken, a statistic that has intensified scrutiny over the commercial motives behind the competition.

The event was organised by Enhanced, a company that simultaneously operates a direct-to-consumer telehealth platform selling supplements, hormone therapies, and peptides. Critics have pointed to a stark conflict of interest, suggesting the Games function as a marketing vehicle to drive sales for Enhanced’s services. This tension was highlighted by discrepancies between substances sold on the platform and those used by athletes. For instance, the telehealth service offers GHK-Cu and GLP-1s, neither of which were on the approved list for competitors. Conversely, erythropoietin (EPO), a drug used by 41 per cent of athletes to boost endurance, is not available for purchase on Enhanced’s site.

Enhanced CEO Maximilian Martin and co-founder Christian Angermayer defend their model as a harm-reduction strategy, arguing that medical supervision is superior to unsupervised online purchases of unregulated substances. Martin stated that the company aims to be a steward of safe biohacking, ensuring athletes and consumers do not resort to ordering untested peptides from overseas sources. However, the disconnect between the drugs athletes use and those sold to the public remains a point of contention for observers and regulators alike.

The debate over bodily autonomy versus safety was further complicated by statements from athletes. Retired swimmer James Magnussen, a three-time Olympic medalist, made factually incorrect claims regarding the long-term effects of COVID-19 vaccines during media scrums. Meanwhile, Hunter Armstrong, who competed without doping and won $375,000 in prize money, expressed concern about unsafe procedures for young people, though he maintained that individuals should have the right to choose what they put in their bodies.

Experts warn that biohacking is not a substitute for fundamental health practices. Dr Ian Boardley and Martin Chandler from the University of Birmingham emphasised that genetic factors play a significant role in individual responses to treatments and that sleep, exercise, and nutrition remain essential. As regulatory landscapes shift under figures such as Health Secretary RFK Jr., the ability for investors and consumers to distinguish between marketing hype and scientific evidence will become increasingly critical in the wellness sector.